Published in Stroke on September 22, 1972
Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev (2014) 1.63
Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med Genet (2007) 1.44
Relation between extent of coronary artery disease and blood viscosity. Br Med J (1980) 1.42
Anemia and red blood cell transfusion in neurocritical care. Crit Care (2009) 1.23
Comparison of leukocyte count and function in smoking and nonsmoking young men. Infect Immun (1975) 1.21
Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells. Exp Hematol (2008) 0.96
Blood viscosity after splenectomy. Br Med J (Clin Res Ed) (1981) 0.91
Rates and predictors of stroke-associated case fatality in black Central African patients. Cardiovasc J Afr (2008) 0.90
The effect of isovolaemic haemodilution and intravenous glycerol on the sequelae of middle cerebral artery occlusion in the rat. J Neurol Neurosurg Psychiatry (1986) 0.88
Mechanisms linking red blood cell disorders and cardiovascular diseases. Biomed Res Int (2015) 0.83
Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol (2008) 0.80
The perioperative management of patients with polycythaemia. Ann R Coll Surg Engl (1980) 0.80
Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis. Pediatr Blood Cancer (2010) 0.78
Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults. Stroke (2016) 0.77
Snoring as a risk factor for ischemic heart disease and stroke in men. Br Med J (Clin Res Ed) (1987) 0.75
Expanding role of a blood center. Asian J Transfus Sci (2012) 0.75
Hemoglobin and hematocrit as risk factors in below-the-knee amputation for incipient gangrene. Arch Orthop Trauma Surg (1988) 0.75
Non-atheromatous causes of cerebral infarction. Postgrad Med J (1984) 0.75
Erythrapheresis in polycythemia. Br Med J (Clin Res Ed) (1983) 0.75
Brain infarction and hemorrhage in young and middle-aged adults. West J Med (1984) 0.75
Managing disability from stroke. Can Fam Physician (1986) 0.75
Second European conference on clinical haemorheology. J R Soc Med (1982) 0.75
The high oxygen affinity haemoglobin Nantes: a family case description. Blood Transfus (2014) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Inverse association of dietary fat with development of ischemic stroke in men. JAMA (1998) 4.20
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Curved DNA without A-A: experimental estimation of all 16 DNA wedge angles. Proc Natl Acad Sci U S A (1991) 3.61
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell (2001) 3.34
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer (2001) 3.23
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
The recent decrease in CHD mortality. Prev Med (1975) 3.16
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg (1993) 2.91
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86